Teva Pharmaceuticals operates a global network of manufacturing, research, and commercial sites that shape how medicines reach patients. Understanding the key locations and how they are organized helps stakeholders gauge reliability, compliance, and local impact.
Below is a concise overview of Teva’s footprint, followed by deeper sections on operations, innovation, regulation, and FAQs.
| Region | Key Facility | Primary Function | Regulatory Authorization |
|---|---|---|---|
| North America | Snyder, Texas | Active pharmaceutical ingredient (API) synthesis | FDA, cGMP |
| Europe | Kfar Saba, Israel | Advanced therapy product development | EMA, ISO 13485 |
| Europe | Tirat Carmel, Israel | Solid dose manufacturing and packaging | EMA, MHRA |
| Asia | Shanghai, China | API process development and scale-up | NMPA, ICH Q7 |
| Latin America | Ribeirão Preto, Brazil | Finished dosage formulation and distribution | ANVISA, WHO GMP |
Operational Footprint and Supply Chain Resilience
Manufacturing Network Design
Teva Pharmaceuticals locations are strategically positioned to balance cost efficiency, regulatory alignment, and patient proximity. Each site is calibrated to specific process strengths, from chemical synthesis to final product distribution.
Redundancy across regions helps maintain continuity in case of temporary disruptions, supporting stable supply for essential medicines. Quality standards are harmonized globally while respecting local requirements.
Innovation and Research Centers
Focus Areas
R&D hubs in Israel and the United States prioritize advanced therapies, generic drug bioequivalence, and novel delivery technologies. These locations host cross-functional teams that collaborate closely with regulatory and commercial units.
Investment in data analytics and automation at key sites accelerates development timelines while preserving rigorous safety checks. Centralized knowledge management ensures insights are shared across Teva Pharmaceuticals locations worldwide.
Regulatory and Compliance Landscape
Global Standards Implementation
Facilities align with health authority expectations such as FDA, EMA, and NMPA. Regular audits, risk-based monitoring, and corrective action plans are embedded into site operations to uphold product integrity.
Environmental, health, and safety protocols are tailored to local regulations, reflecting Teva’s commitment to responsible manufacturing across all geographies. Documentation and traceability systems support swift regulatory responses.
Market Access and Local Impact
Community and Patient Reach
By situating production and formulation close to key markets, Teva Pharmaceuticals locations help reduce logistics delays and improve accessibility. Local hiring and supplier engagement generate socioeconomic benefits in surrounding areas.
Strategic partnerships with governments and payers ensure that products manufactured at these sites meet national formularies and reimbursement criteria, enhancing patient adherence and outcomes.
Global Operations and Future Expansion
- Maintain redundant manufacturing capacity across regions to safeguard supply continuity.
- Invest in digital quality systems and real-time data monitoring at all Teva Pharmaceuticals locations.
- Standardize regulatory documentation while respecting local compliance nuances.
- Strengthen community partnerships near major facilities to enhance social impact.
- Prioritize sustainable process improvements and energy efficiency upgrades.
FAQ
Reader questions
Which site is responsible for API production in North America?
The Snyder, Texas facility serves as a primary center for active pharmaceutical ingredient synthesis in North America, operating under FDA and current good manufacturing practice (cGMP) standards.
How does Teva ensure quality across its global locations?
A unified quality management system, combined with regular internal and regulatory audits, standardizes processes across Teva Pharmaceuticals locations while allowing site-specific adaptations.
What role does the Kfar Saba facility play in the innovation pipeline?
Kfar Saba focuses on advanced therapy product development, integrating research, regulatory science, and early commercialization planning within the European and global portfolios.
Are there sustainability initiatives tied to these locations?
Each site implements energy efficiency measures, waste reduction programs, and water stewardship efforts aligned with global sustainability goals and local environmental regulations.